Our results demonstrated that DSF treatment suppressed the expression of breast CSCs markers (ALDH+, CD44+/CD24−), and abolished the sphere-forming ability in breast cancer cells at a concentration of 10–15 μM. Here, CD44 is linked to breast cancer.